The greater the number of risk factors in patients with cutaneous squamous cell carcinoma, the higher the likelihood of poor ...

Anti-PD1 immunotherapy improves outcomes for patients with metastatic cutaneous squamous cell carcinoma (cSCC). But we need to know more about who will, or will not, respond adequately.

Skin Grafts: Using healthy skin from ... Kolkata shares the role of surgery in head and neck squamous cell carcinoma: Early-stage disease (stage I & II):70 to 90 % (5 years disease-free survival ...

Interim Results from clinical study for cutaneous carcinomas presented at Late-Breaking Research SessionMarlborough, Massachusetts--(Newsfile ...

except for 1 patient with end-stage renal disease undergoing hemodialysis who received sorafenib 200 mg daily. Two patients reported a history of previous treatment for AK and SCC before the ...

Anti-PD1 immunotherapy improves outcomes for patients with metastatic cutaneous squamous cell carcinoma (cSCC). But we need to know more about who will, or will not, respond adequately.